Cruse Michael 4
4 · Reneo Pharmaceuticals, Inc. · Filed Aug 26, 2021
Insider Transaction Report
Form 4
Cruse Michael
Senior VP-Corporate Operations
Transactions
- Purchase
Common Stock
2021-08-25$7.45/sh+2,500$18,616→ 2,500 total
Footnotes (1)
- [F1]The weighted average purchase price for the transaction was $7.4464. The shares were purchased at a range of prices between $7.425 and $7.45. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.